What question did this study set out to answer?

The aim is to explore the potential of PROTAC technology in degrading xanthine oxidase to treat hyperuricemia.

April 5, 2026Journal of Materials Chemistry B0 citations

Targeting xanthine oxidase degradation via PROTAC technology for the treatment of hyperuricaemia

XDXue DongJiangsu University LWLin WangJiangsu University SLSijia LinJiangsu University

Key Points

The aim is to explore the potential of PROTAC technology in degrading xanthine oxidase to treat hyperuricemia.
Utilization of PROTAC technology to target and degrade xanthine oxidase
Analysis of uric acid levels pre- and post-intervention
Evaluation of systemic effects of xanthine oxidase degradation
Effective reduction of serum uric acid levels observed after treatment
Significant improvement in associated symptoms of hyperuricemia
Demonstrated potential for PROTAC as a therapeutic approach in metabolic disorders

Abstract

Hyperuricemia, characterized by an elevated serum uric acid level due to the abnormal xanthine oxidase (XOD)-mediated uric acid production, is generally associated with multiple systemic disorders. In this study, XOD-targeting...

AI से पूछें

Bookmark

View Full Paper